Alessandro Rambaldi to Combined Modality Therapy
This is a "connection" page, showing publications Alessandro Rambaldi has written about Combined Modality Therapy.
Connection Strength
0.129
-
Randomized Trial Comparing R-CHOP Versus High-Dose Sequential Chemotherapy in High-Risk Patients With Diffuse Large B-Cell Lymphomas. J Clin Oncol. 2016 11 20; 34(33):4015-4022.
Score: 0.084
-
Cord blood-derived cytokine-induced killer cells combined with blinatumomab as a therapeutic strategy for CD19+ tumors. Cytotherapy. 2018 08; 20(8):1077-1088.
Score: 0.024
-
Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia. N Engl J Med. 2017 03 02; 376(9):836-847.
Score: 0.021